Clinical Trial Update: Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety and immune response of GlaxoSmithKline's investigational pneumococcal vaccine in adults aged 50 to 64, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Pneumonia

Drugs mentioned

• Investigational pneumococcal vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pneumonia, Bacterial | Phase 1 | Status: RECRUITING